openPR Logo
Press release

Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022 Report

05-07-2018 06:15 AM CET | Health & Medicine

Press release from: Kuick Resarch

Personalized Cancer Vaccines Market and Clinical Innovation

Oncological segment has gained a great momentum with the advent of modern technologies and the better equipped sequencing methodology. Over the past years, there has been gradual paradigm shift from traditional medicine and accelerated acceptance towards the precision medication. Physicians are opting for the personalization of the medicines according to the genomic makeup of the patient.

Download Report Sample Weblink:

For Report Sample Contact:

Table of Contents

1. Personalized Vaccine: Trail Towards Cancer
1.1 Prologue to Personalized Cancer Immunotherapy
1.2 Advent of Personalized Cancer Vaccine

2. Perception of Personalized Vaccinomics
2.1 Genetic Heterogeneity by HLA System
2.2 Genesis of Tumor Neoantigens

3. Identification of Tumor Neoantigens
3.1 Conventional Methodologies
3.2 Next Genome Sequencing Approach

4. Development of Personalized Vaccines
4.1 Development Process of Personal Cancer Vaccine
4.2 Economic Aspects of Personalized Cancer Vaccine

5. Mechanism of Personalized Vaccines
5.1 Rationale of Personal Cancer Vaccine
5.2 Neoantigens and Immune Interactions

6. Application of Neoantigens in Therapeutics
6.1 Adoptive T Cell Therapy
6.2 Checkpoint Blockade

7. Categories of Personalized Cancer Vaccines
7.1 Personalized Peptide Vaccination (PPV)
7.2 DNA Cancer Vaccines
7.3 RNA Based Vaccines
7.4 Dendritic Cell Vaccines
7.5 Whole Tumor Cell Vaccines
7.6 Recombinant Virus Vaccines

8. Biomarkers for Personalized Vaccines
8.1 Pharmacogenomic Biomarkers
8.2 Prognostic and Predictive Biomarkers
8.3 Immune Checkpoint Biomarkers

9. Personalized Vaccines for Varied Cancers
9.1 Melanoma
9.2 Lung Cancer
9.3 Breast Cancer
9.4 Colorectal Cancer
9.5 Leukemia
9.6 Prostate cancer
9.7 Cervical Cancer
9.8 Gastric Cancer
9.9 Brain Tumor
9.10 Renal Cancer

10. Pharmacogenomics of Personalization
10.1 Pharmacogenomics towards Genomic Polymorphism
10.2 Somatic Mutations in Cancer Pharmacogenomics
10.3 Applications of Pharmacogenomics

11. Personalized Vaccines Market Overview
11.1 Market Trends Towards Therapeutic Personalization
11.2 Mergers and Acquisitions for Personalized Therapy

12. Global Personalized Vaccines Market Dynamics
12.1 Personalization Growth Drivers
12.1.1 Increasing Cancer Incidences
12.1.2 Cancer Heterogenetic Environment
12.1.3 High Level of Specificity
12.1.4 Government Initiatives
12.1.5 Reduced Genome Sequencing Cost and Time
12.1.6 Sustained Level of Innovation
12.2 Personalization Major Challenges

13. Global Personalized Cancer Vaccines Market Future Aspects

14. Competitive Landscape
14.1 Advaxis Inc.
14.2 Avax Technologies
14.3 BioNtech
14.4 Celldex
14.5 Genentech Inc.
14.6 Genocea
14.7 ISA Pharmaceuticals
14.8 Merck and Co.
14.9 Moderna
14.10 Neon Therapeutics

Figure 1-1: Categorization of the Cancer Immunotherapeutics Towards Cancer Vaccines
Figure 1-2: Illustration of Advantages Provided by the Targeting Neoantigens
Figure 2-1: Distinguishing Features of Driver and Passenger Gene Mutations
Figure 3-1: Identification of Tumor Antigens by Conventional Approach
Figure 3-2: Number of Mutation Derived Neoantigens in Human Cancer
Figure 3-3: Identification of Tumor Specific Neoantigens by Next Generation Sequencing
Figure 4-1: Illustration of Development of personalized Cancer Vaccines
Figure 4-2: Estimated Cost for Cancer Cell’s Genome Sequencing (US$)
Figure 4-3: Estimated Economic (US$) and Timeline (Weeks) Projections of Personalized Cancer Vaccine
Figure 5-1: Illustration of Development of Personalized Cancer Vaccines
Figure 5-2: Immune Stimulation by T-Cells with Personalized Cancer Vaccine
Figure 5-3: Immune Response Stimulation by B Cells with Personalized Cancer Vaccines
Figure 6-1: Route of Action of Adoptive T-Cell Mechanism in Individual
Figure 6-2: Clinical Aspects of Tumor Infiltrating T Cells in Cancer
Figure 6-3: Typical Mechanism of T Cell Activation via Signal Binding
Figure 6-4: Schematic Representation of Evolution of CARs Design
Figure 6-5: Mechanism of Cell Checkpoint Blockade in Cancer Vaccines
Figure 6-6: Mechanism of Cytotoxic T-Lymphocyte Associated Antigen-4 (CTLA-4)
Figure 6-7: Mechanism of PDL-1 Checkpoint Blockade in Tumor Cells
Figure 7-1: Differences between Conventional and Personalized Peptide Vaccine
Figure 7-2: The Representation of Template of a Polypeptide DNA Vaccine
Figure 7-3: Principle Structure of Synthetic m-RNA Developed with Specific Antigen
Figure 7-4: Representation of Ex-Vivo Preparation of Dendritic Cell based Vaccines
Figure 7-5: The Tumor Microenvironment Suppresses Efficacy by DC based Vaccines
Figure 7-6: Mechanism of Personalized Autologous Whole Tumor Cancer Vaccine
Figure 7-7: Representation of Replicative Virus Encoding a HSP Gene for Antitumor Activity
Figure 8-1: Illustration of Various Types of Biomarkers in Personalized Medicine
Figure 8-2: Roadmap of Development of Predictive Biomarkers
Figure 8-3: High Throughput Immune Assessment for Biomarker Discovery
Figure 9-1: Alterations in Mechanism of Cell Cycle Control of CDKN2A
Figure 9-2: Illustration of Targetable Oncogenic Drivers in Non-Small Lung Cancer
Figure 9-3: Personalized Strategies to Attain the Target of Interest in Acute Myeloid Leukemia
Figure 9-4: Prevalence of Cervical Cancer in Women in Developed and Developing Countries
Figure 9-5: Proportion of Genetic Abnormalities Present in Gastric Cancer
Figure 9-6: Classification of Gliomas into Four Grades Based as WHO Classification
Figure 9-7: Illustration of Loss of VHL Expression Leads to Renal Cell Carcinoma
Figure 10-1: Demonstration of Genomic Polymorphism in Pharmacogenomics
Figure 10-2: The Sources of Pharmacological and Pharmacogenetic Variability’s
Figure 10-3: Applications of Pharmacogenomics in Cancer Precision Medicines
Figure 11-1: Personalized Cancer Vaccine Market Opportunity Assessment (US$ Million), 2017-2022
Figure 11-2: Representation of the Commercial Oncological Trials by Segment
Figure 12-1: Representation of Growth Drivers in Personalized Cancer Vaccines
Figure 12-2: Illustrations of the Reduced Sequencing Cost of Human Genome
Figure 12-3: Major Challenges faced by the Personalized Cancer Vaccines

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022 Report here

News-ID: 1040668 • Views: 322

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 35 Billion By 2026
Global cell therapy market is expected to surpass US$ 35 Billion by 2026 as per recent report “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” published by Kuick Research. Increasing investment, gaining research and development activities along with new technological advancement will drive the global cell therapy market. Download Report:,-clinical-trials,-therapy-price-and-opportunity-insight-2026.php “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” Report Highlights: • Global Cell Therapy
Cell Therapy Market Size Growth Cell Therapy Clinical Trials Market Forecast 202 …
Cell therapies are still in the infancy stages of the clinical development and are expected to evolve in the market with a vast number of opportunities in the healthcare industry. In order to form a stable base for process evaluation and development it will be essential to understand the quality of cell based products. With an increasing number of cell therapies and clinical indications being assessed, it is clear that
Global Cell Therapy Market Size Analysis Clinical Trials Growth Forecast 2026
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
CAR T Cell Therapy Changing The Cancer Oncology Drug Market Landscape
" Global CAR T Cell Therapy Market & Clinical Trials Insight 2024" Report Highlights: • CAR T-Cell Therapies Delivery Pipeline & Mechanism of Action • Sales Analysis of CAR - T Cell Therapy • CAR - T Cell Therapy Market Opportunity: US$ 700 Million • CAR-T Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies • CAR-T Cell Therapies in Highest Phase: Preclinical • Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) • Global Market Scenario of

All 5 Releases

More Releases for Figure

Figure Skating Equipment Market Report 2018: Segmentation by Type (Figure Skate …
Global Figure Skating Equipment market research report provides company profile for SP-Teri, Graf Skate, Riedell Shoes, Roces, American Athletic, Rollerblade, Winnwell, Dongguan King Line, Jackson Ultima, HD Sports(MK Blades, John Wilson), Edea, Risport Skates, Paramount Skates and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Figure Skating Equipment Sales Market Segmentation and Forecast to 2025
This report studies the global Figure Skating Equipment market status and forecast, categorizes the global Figure Skating Equipment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The figure skating equipment includes the Figure Skate Boots, Figure Skate Blades and Figure
Global Leisure Boats Market Dynamic, Value, Figure, Forecast 2018-2025
Qyresearchreports include new market research report Global Leisure Boats Market Professional Survey Report 2018 to its huge collection of research reports. This report studies Leisure Boats in Global market,especially in North America,China,Europe,Southeast Asia,Japan and India,with production,revenue,consumption,import and export in these regions,from 2013 to 2018,and forecast to 2025. This report focuses on top manufacturers in global market,with production,price,revenue and market share for each manufacturer,covering Riva Sunseeker Ferretti Lurssen Azimut Wally Princess Pershing Free Sample of this report is available upon request @
Global Protective Packaging Market Dynamic, Value, Figure, Forecast 2018-2025
Qyresearchreports include new market research report Global Protective Packaging Market Professional Survey Report 2018 to its huge collection of research reports. This report studies Protective Packaging in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and
Global Figure Skating Equipment Market Size,Share : Industry Trends 2022
"The Report Global Figure Skating Equipment Market by Manufacturers, Countries, Type and Application, Forecast to 2022 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" This report studies the figure skating equipment, which includes the Figure Skate Boots, Figure Skate Blades and Figure Skates. Not similar with the common shoes, people should run in and adapt to figure skating equipment, which means they
Long-lasting Performance Improvement with Key Figure Analysis
Vienna/Reutlingen, October 17, 2012 – Manz, a leading high-tech mechanical engineering company, is optimizing its processes in strategic sourcing in order to recognize the risks and potential associated with each supplier early on so that the sourcing department can react to them in time. POOL4TOOL’s customized eSolutions localize and analyze key figures that are relevant to the decision making process, and displays these figures in a comprehensive and transparent way.